Company Quick10K Filing
iGambit
10-K 2019-12-31 Filed 2020-05-14
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-20
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-20
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-18
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-22
10-Q 2016-03-31 Filed 2016-05-23
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-18
10-Q 2015-03-31 Filed 2015-05-14
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-13
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-04-01
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-15
10-Q 2013-03-31 Filed 2013-07-23
10-K 2012-12-31 Filed 2013-06-20
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-10
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-22
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-06-17
10-K 2009-12-31 Filed 2010-06-15
8-K 2020-06-03
8-K 2020-05-19
8-K 2020-05-15
8-K 2020-04-13
8-K 2019-11-19
8-K 2019-11-12
8-K 2019-11-01
8-K 2019-08-09
8-K 2019-06-27
8-K 2018-10-29
8-K 2018-08-06
8-K 2018-06-19

iGambit Financials

IGMB Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Pacific Ventures (PACV) 0 25% -3.8 -65% 1,799 5,073 3,514 883 -1,171 -615 2,318
Galileo Acquisition (GLEO)
Gafisa (GFA)
VNUE (VNUE) 0 0% -2.0 -621% 168 3,666 200 0 -1,042 -634 1,242
New You (NWYU)
Angiosoma (SOAN) 0 64% -0.2 -475% 142 828 0 0 -675 -315 66
YaSheng Group (HERB)
Sprout Social (SPT)
Force Protection Video Equipment (FPVD) 0 56% 0.0 -394% 204 583 216 120 -802 -829 -1
United States Diesel-Heating Oil Fund (UHN) 0 0% -0.0 0 0 677 0 639 639 -0
FS Investment (FSIC)
XsunX (XSNX) 0 47% 0.1 1,089% 215 2,451 1,609 753 2,344 2,417 194
Nate's Food (NHMD) 0 92% -0.1 -6,857% 7 825 3 3 -481 -455 30
Crescent Acquisition Corp (CRSAU)
iGambit (IGMB) 0 -64% 0.0 -108% 2,105 1,465 21 -13 -2,269 -1,859 -10
Argentum 47 (ARGQ) 0 0% 0.0 -85% 1,487 2,005 87 0 -1,268 -1,187 -3
Regen Biopharma (RGBP) 0 0% -0.3 -4,777% 114 12,900 82 0 -5,461 -5,186 1,325
Kura Sushi (KRUS)
GH Capital (GHHC) 0 66% -0.0 -2,680% 89 331 211 139 -2,374 -2,374 59
Anchiano Therapeutics (ANCN)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302019-03-312019-09-30
Cash4693042252166533641054910221727590332133394119132243322117441596051710
Accounts Receivable279256269212161158158157207181135971008211210814523033044154640116211010
Inventory2121112727
PP&E21201923211918161513111110812111040342924154443321
Assets2,1922,0121,8911,7651,7071,4967466701,0911,0591,0717224962811942724107,3687,4667,4797,4965111,7236,8896,5703,3293,1842,9832,4462,105
Accounts Payable-69263298380303434431392415317330293285301309315637634666746356374
Long-Term Debt104402,3392,3392,3392,339
Liabilities2832561,4391,3011,1876,0776,1446,2536,0526,3806,6786227349601,0621,1171,2231,465
Stockholders' Equity1,9081,7566,2665,8362,3692,1221,8651,223640
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302019-03-312019-09-30
Revenue477410484480429416268363412397290240310269249300348312-4864045907984519-54458
Cost of Revenue22219122225522316314311615013497103124115124136167126-42132580148888810
Gross Profit256219262225207253125247262263193137187154125165180186-654015657904-1011-13-4-4-3-2
R&D
SG&A4514595024974334381,015450428421393272388338385308229259170559581459-1,1501671,239723-315234311190187
Tax-66-78-8400
Net Income-153-153-164-138-114-1,208-203589-15822-162-75-186-262-145-52-75355-239-96217-7,314-242-1,6476,325-3,854-610-726-559-374
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302019-03-312019-09-30
Cash Operating-202-1161555-264-255-585312-1903616-254-199-120-0-28-303-2856423-76-116-243-156-191-273-219-102
Cash Investing3737-1435-13-330-10-500-5000-911-42-033000
Cash Financing04-55-30302613178-54-3584176215168152324210108